Distribution and bioactivity of the Ret-specific D4 aptamer in three-dimensional collagen gel cultures

Molecular Cancer Therapeutics

Volumn 7, Issue 10, 2008, Pages 3381-3388

  Vento, Maria Teresa ^a   Iuorio, Marco ^a   Netti, Paolo A ^a,c   Ducongè, Frederic ^d   Tavitian, Bertrand ^d   Franciscis, Vittoriode ^b   Cerchia, Laura ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; COLLAGEN GEL; D4 APTAMER; PROTEIN RET; UNCLASSIFIED DRUG; COLLAGEN; MUTANT PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DISTRIBUTION; EMBRYO; FIBROBLAST; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR; ANIMAL; ANTIBODY SPECIFICITY; CELL CULTURE; DIFFUSION; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENCE; GEL; METABOLISM; RAT; RNA TRANSPORT; SPECTROSCOPY;

ANIMALS; ANTIBODY SPECIFICITY; APTAMERS, NUCLEOTIDE; CELLS, CULTURED; COLLAGEN; DIFFUSION; FLUORESCENCE; GELS; MICE; MUTANT PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RATS; RNA TRANSPORT; SPECTRUM ANALYSIS;

EID: 55749114762     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-08-0580     Document Type: Article

References (18)

1. Meng X, Lindahl M, Hyvönen ME, et al. Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science 2000;287:1489-93.
2. Sariola H, Saarma M. Novel functions and signalling pathways for GDNF. J Cell Sci 2003;116:3855-62.
3. Cerchia L, Ducongé F, Pestourie C, et al. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol 2005;3:123.
4. Pestourie C, Cerchia L, Gombert K, et al. Comparison of different strategies to select aptamers against a transmembrane protein target. Oligonucleotides 2006;16:323-35.
5. Esposito CL, D'Alessio A, De Franciscis V, Cerchia L. A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation. PLoS ONE 2008;3:1643.
6. Saltzman WM, Parkhurst MR, Parsons-Wingerter P, Zhu WH. Three-dimensional cell cultures mimic tissues. Ann N Y Acad Sci 1992;665:259-73.
7. Campbell RB. Tumor physiology and delivery of nanopharmaceuticals. Anticancer Agents Med Chem 2006;6:503-12.
8. Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006;7:211-24.
9. Cerchia L, Libri D, Carlomagno MS, de Franciscis V. The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret. Biochem J 2003;372:897-903.
10. Haustein E, Schwille P. Fluorescence correlation spectroscopy: novel variations of an established technique. Annu Rev Biophys Biomol Struct 2007;36:151-69.
11. Ramanujan S, Pluen A, McKee TD, Brown EB, Boucher Y, Jain RK. Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. Biophys J 2002;8:1650-60.
12. Mahoney MJ, Krewson C, Miller J, Saltzman WM. Impact of cell type and density on nerve growth factor distribution and bioactivity in 3-dimensional collagen gel cultures. Tissue Eng 2006;12:1915-27.
13. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990;249:505-10.
14. Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: an emerging class of therapeutics. Annu Rev Med 2005;56:555-83.
15. Eyetech Study Group. Preclinical and phase IA clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina 2002;22:143-52.
16. Hicke BJ, Stephens AW. Escort aptamers: a delivery service for diagnosis and therapy. J Clin Invest 2000;106:923-8.
17. Cerchia L, Hamm J, Libri D, et al. Nucleic acid aptamers in cancer medicine. FEBS Lett 2002;528:12-6.
18. Cerchia L, de Franciscis V. Nucleic acid-based aptamers as promising therapeutics in neoplastic diseases. Methods Mol Biol 2007;361:187-200.